Eritoran
Title: Eritoran
CAS Registry Number: 185955-34-4
CAS Name: 3-O-Decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono-b-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-a-D-glucopyranose 1-(dihydrogen phosphate)
Molecular Formula: C66H126N2O19P2
Molecular Weight: 1313.66
Percent Composition: C 60.34%, H 9.67%, N 2.13%, O 23.14%, P 4.72%
Literature References: Toll-like receptor 4 (TLR4) antagonist. Synthetic analog of the lipid A component of endotoxin, a major constituent of the outer membrane of Gram negative bacteria. Prepn: W. J. Christ et al., WO 9639411; eidem, US 5750664 (1996, 1998 both to Eisai). Pharmacology: M. Mullarkey et al., J. Pharmacol. Exp. Ther. 304, 1093 (2003). Clinical pharmacokinetics: Y. N. Wong et al., J. Clin. Pharmacol. 43, 735 (2003); and lipid distribution profile: D. P. Rossignol et al., Antimicrob. Agents Chemother. 48, 3233 (2004). Clinical evaluation in experimental endotoxemia: M. Lynn et al., J. Pharmacol. Exp. Ther. 308, 175 (2004). Review of pharmacology and clinical experience: D. P. Rossignol, M. Lynn, Curr. Opin. Invest. Drugs 6, 496-502 (2005).
 
Derivative Type: Tetrasodium salt
CAS Registry Number: 185954-98-7
Manufacturers' Codes: E-5564; B-1287
Molecular Formula: C66H122N2Na4O19P2
Molecular Weight: 1401.58
Percent Composition: C 56.56%, H 8.77%, N 2.00%, Na 6.56%, O 21.69%, P 4.42%
 
Therap-Cat: In treatment of severe sepsis.
Keywords: Antisepsis.

Others monographs:
SulfamethomidineErythrityl TetranitrateCorn Steep LiquorZinc Lactate
D-Galacturonic AcidGrepafloxacinAmmonium CaprylateOrnoprostil
2,2'-DichlorobenzidineCaprylic AldehydeFerric SulfateDimoxyline
Bismuth Iodide Oxide2,4,6-TrinitrotolueneMetconazoleRhododendrin
©2016 DrugLead US FDA&EMEA